Brazilian version of the CHOP INTEND scale: cross-cultural adaptation and validation

Abstract

Background Spinal muscular atrophy (SMA) is a rare genetic disease that causes progressive muscle weakness and impacts motor function. The type I is the most severe presentation and affects infants before 6 months old. In addition, the instruments available for assessing motor function have limitations when applied to infants with neuromuscular diseases and significant muscle weakness.

Keywords

• Muscular Atrophy, Spinal
• Growth and Development
• Validation Study
• Atrofia Muscular Espinal
• Crescimento e Desenvolvimento
• Estudos de Validação